Fiala E S, Sohn O S, Puz C, Czerniak R
J Cancer Res Clin Oncol. 1987;113(2):145-50. doi: 10.1007/BF00391436.
Using a hybrid ion-exchange reverse phase HPLC system, we found that F344 rat liver microsomes, in the presence of an NADPH-generating system, can metabolize methylazoxymethanol (MAM), a colon and liver carcinogen, to methanol and formic acid. This is in contrast to the spontaneous decomposition of MAM which yields methanol and formaldehyde. The metabolism of MAM by rat liver microsomes is sensitive to inhibition by carbon monoxide as well as to inhibition by 3-methylpyrazole (3-MeP) and 4-iodopyrazole (4-IP), with 4-IP being more potent in this respect than 3-MeP. Pretreatment of rats with 4-IP decreased the level of MAM acetate-induced DNA methylation in both the liver and the colon mucosa. In contrast, pretreatment with 3-MeP decreased MAM acetate-induced liver DNA methylation, but increased DNA methylation in the colon mucosa. This differential effect of the two compounds on DNA methylation in the liver and the colon suggests that different enzymes are responsible for activation of the carcinogen in the two organs.
使用混合离子交换反相高效液相色谱系统,我们发现,在存在NADPH生成系统的情况下,F344大鼠肝微粒体能够将结肠和肝癌致癌物甲基偶氮甲醇(MAM)代谢为甲醇和甲酸。这与MAM自发分解生成甲醇和甲醛形成对比。大鼠肝微粒体对MAM的代谢对一氧化碳抑制以及3 - 甲基吡唑(3 - MeP)和4 - 碘吡唑(4 - IP)抑制敏感,在这方面4 - IP比3 - MeP更有效。用4 - IP预处理大鼠可降低MAM乙酸盐诱导的肝脏和结肠黏膜中的DNA甲基化水平。相比之下,用3 - MeP预处理可降低MAM乙酸盐诱导的肝脏DNA甲基化,但增加结肠黏膜中的DNA甲基化。这两种化合物对肝脏和结肠中DNA甲基化的不同作用表明,不同的酶负责这两个器官中致癌物的活化。